Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 8SDG | 8SDG | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43 | |
| 8SDH | 8SDH | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56 | |
| 8SGA | 8SGA | Crystal structure of 770E11, a monoclonal antibody isolated from a human Epstein-Barr virus seropositive donor | |
| 8SGB | 8SGB | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
| 8SGM | 8SGM | Crystal Structure of CD1d-lipid complexed with Beta-2-Microglobulin, TCR Alpha-Chain and TCR Beta-Chain | |
| 8SGN | 8SGN | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy651H02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SGO | 8SGO | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus pregnenolone sulfate | |
| 8SI9 | 8SI9 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus allopregnanolone | |
| 8SIC | 8SIC | Crystal structure of Epstein-Barr virus glycoprotein 350 (gp350) in complex with Cy137C02, a monoclonal antibody isolated from macaques immunized with a gp350 nanoparticle vaccine | |
| 8SID | 8SID | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus dehydroepiandrosterone sulfate | |
| 8SIQ | 8SIQ | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibodies CC25.36 and CV38-142 Fab | |
| 8SIR | 8SIR | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC25.54 Fab | |
| 8SIS | 8SIS | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.2 Fab | |
| 8SIT | 8SIT | Crystal structure of SARS-CoV-2 spike receptor-binding domain in complex with broadly neutralizing antibody CC84.24 Fab | |
| 8SJK | 8SJK | Pembrolizumab Caffeine crystal | |
| 8SK5 | 8SK5 | Crystal structure of the SARS-CoV-2 neutralizing VHH 7A9 bound to the spike receptor binding domain | |
| 8SK7 | 8SK7 | Cryo-EM structure of designed Influenza HA binder, HA_20, bound to Influenza HA (Strain: Iowa43) | |
| 8SM1 | 8SM1 | CRYSTAL STRUCTURE OF HUMAN ANTIBODY 769A9 IN COMPLEX WITH EPSTEIN-BARR VIRUS MAJOR GLYCOPROTEIN GP350 | |
| 8SMI | 8SMI | Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain | |
| 8SMN | 8SMN | Xenopus laevis hyaluronan synthase 1, nascent HA polymer bound state | |
| 8SMT | 8SMT | Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain | |
| 8SNC | 8SNC | Chlorella virus Hyaluronan Synthase bound to GlcA extended GlcNAc primer | |
| 8SND | 8SND | Chlorella virus Hyaluronan Synthase bound to GlcNAc primer and UDP-GlcA | |
| 8SNE | 8SNE | Chlorella virus Hyaluronan Synthase bound to GlcA extended GlcNAc primer and UDP | |
| 8SO3 | 8SO3 | CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 | |
| 8SOS | 8SOS | Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17 | |
| 8SOS | 8SOS | Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17 | |
| 8SPH | 8SPH | Crystal structure of chimeric omicron RBD (strain XBB.1) complexed with human ACE2 | |
| 8SPI | 8SPI | Crystal structure of chimeric omicron RBD (strain XBB.1.5) complexed with human ACE2 | |
| 8SQN | 8SQN | CryoEM structure of Western equine encephalitis virus VLP in complex with the chimeric Du-D1-Mo-D2 MXRA8 receptor | |
| 8SR0 | 8SR0 | CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 local refined | |
| 8SSZ | 8SSZ | The 2alpha3beta stoichiometry of full-length human alpha4beta2 nicotinic acetylcholine receptor in complex with acetylcholine and calcium | |
| 8ST0 | 8ST0 | The 2alpha3beta stoichiometry of full-length human alpha4beta2 nicotinic acetylcholine receptor in complex with acetylcholine | |
| 8ST1 | 8ST1 | The 3alpha2beta stoichiometry of human alpha4beta2 nicotinic acetylcholine receptor in complex with acetylcholine and calcium | |
| 8ST2 | 8ST2 | The 3alpha2beta stoichiometry of human alpha4beta2 nicotinic acetylcholine receptor in complex with acetylcholine | |
| 8ST3 | 8ST3 | The 2alpha3beta stoichiometry of human alpha4beta2 nicotinic acetylcholine receptor in complex with acetylcholine and calcium | |
| 8ST4 | 8ST4 | The 2alpha3beta stoichiometry of human alpha4beta2 nicotinic acetylcholine receptor in complex with acetylcholine | |
| 8SW4 | 8SW4 | BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3 | |
| 8SW7 | 8SW7 | BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP1 | |
| 8SWH | 8SWH | Local refinement of SARS-CoV-2 (HP-GSAS-Mut7) spike NTD in complex with TXG-0078 Fab | |
| 8SWV | 8SWV | BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1 | |
| 8SWW | 8SWW | BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3 | |
| 8SWX | 8SWX | BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4 | |
| 8SX3 | 8SX3 | 10E8-GT10.2 immunogen in complex with human Fab 10E8 and mouse Fab W6-10 | |
| 8SZO | 8SZO | Canavalia villosa lectin in complex with alpha-methyl-mannoside | |
| 8SZY | 8SZY | Crystal Structure of Heterotrimeric Anti-TIGIT Fabs in complex with human TIGIT | |
| 8T1G | 8T1G | The crystal structure of hemagglutinin form a h7n9 influenza virus (a/shanghai/1/2013) in complex with antibody 1E11 | |
| 8T2E | 8T2E | BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3 | |
| 8T2F | 8T2F | BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289 | |
| 8T2U | 8T2U | Cryo-EM Structures of Full-length Integrin alphaIIbbeta3 in Native Lipids complexed with Eptifibatide |
